Daniella Mehalik
Direttore Finanziario/CFO presso PSYCHEMEDICS CORPORATION
Profilo
Daniella Mehalik is currently the Vice President-Finance & Treasurer at Psychemedics Corp.
Prior to this, she worked as a Controller at NeuBase Therapeutics, Inc. from 2021 to 2023 and at DxTx Medical, Inc. from 2019 to 2021.
She holds undergraduate and graduate degrees from Carlow University Of.
Posizioni attive di Daniella Mehalik
| Società | Posizione | Inizio |
|---|---|---|
| PSYCHEMEDICS CORPORATION | Direttore Finanziario/CFO | 27/11/2023 |
Precedenti posizioni note di Daniella Mehalik
| Società | Posizione | Fine |
|---|---|---|
| NEUBASE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/01/2023 |
| DxTx Medical, Inc. | Comptroller/Controller/Auditor | 01/01/2021 |
Formazione di Daniella Mehalik
| Carlow University Of | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PSYCHEMEDICS CORPORATION | Health Services |
| Aziende private | 2 |
|---|---|
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on March 29, 2002 and is headquartered in Pittsburgh, PA. | Health Technology |
| DxTx Medical, Inc. |
- Borsa valori
- Insiders
- Daniella Mehalik
